Clinical Trial Detail

NCT ID NCT02921256
Title Veliparib and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

rectum adenocarcinoma

Therapies

Veliparib

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Capecitabine + Veliparib

Capecitabine

Age Groups: adult senior

No variant requirements are available.